VIDEO – Allurion co-founder Shantanu Gaur on CNBC’s Mad Money
CNBC – Jim Cramer sat down with the founder of Allurion Technologies to hear about his privately-held biotech company’s revolutionary obesity treatment.
VIDEO – Balloon You Can Swallow Fights Obesity
NBC NEWS – Could a ‘Balloon in a Pill’ Be the Next Weight Loss Weapon?
Allurion Technologies Completes Enrollment in Landmark Pivotal U.S. Clinical Trial for the Elipse® Balloon
BUSINESS WIRE – Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announces completion of enrollment in ENLIGHTEN, a United States clinical trial for the Elipse® Balloon –a procedureless™ gastric balloon for weight loss.
Allurion Technologies announces key additions to the senior management
BUSINESS WIRE – Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced the appointment of four new additions to the senior management team. These new hires bring an array of deep expertise to Allurion in areas including finance, sales, marketing, quality assurance and regulatory affairs.
Balón gástrico sin cirugía: te contamos en qué consiste esta novedosa intervención
Una nueva generación de balones intragástricos, que se colocan sin necesidad de pasar por el quirófano, están saliendo al mercado. Entre ellos, está cogiendo fama la “cápsula Elipse”, o balón elipse, un dispositivo intragástrico innovador, desarrollado por la empresa Allurion y adoptado por numerosas clínicas privadas.
La revolución del programa Elipse
SEVILLA MAGAZINE – Con el programa Elipse no hay restricciones estrictas en la dieta. No obstante, para maximizar la pérdida de peso y optimizar el confort, su nutricionista le hará las recomendaciones más adecuadas para usted, su cuerpo y sus objetivos.
Balón Elipse, el tratamiento más innovador para la pérdida de peso
DIARIO DEL ALTOARAGON – El balón intragástrico Elipse es uno de los tratamientos estrella para perder peso debido a sus grandes ventajas entre las que se destacan que es ingerible y no requiere cirugía, ni endoscopia, ni anestesia.
The balloon that can change your life
ANTI-AGE MAGAZINE – To date, more than 10,000 patients worldwide have been won over by this innovation. Claire, age 42, Elipse patient, tells: “What convinced and reassured me about this programme is the guidance I received from the healthcare professionals and the astounding results. I lost 10 kilos in 4 months, which means I can now run without being out of breath. My children can’t believe it!”
Natick’s Allurion breaks new ground in the weight-loss market
THE METROWEST DAILY NEWS – Gaur and Levy developed the concept when they were second-year students at Harvard Medical School, and noticed a connection between obesity and almost every disease, including cardiovascular disease and Type 2 diabetes. […] According to Gaur, there are 70 million obese people in the U.S., but only 200,000 have weight-loss surgery.
Massachusetts doctors going the startup route
THE BOSTON GLOBE – “I realized that as a practicing physician or surgeon, the absolute impact I could have was constrained by what I could do with my two hands in 24 hours,” said Dr. Samuel Levy, 35, who planned to become a medical oncologist but instead helped found Allurion Technologies in 2009 to take on the obesity epidemic. […] Levy said he can help “patients halfway around the world while I am sleeping”.
Deflating obesity: Allurion hopes its new balloon can help patients with weight loss
WORCESTER BUSINESS JOURNAL – The Elipse Balloon is already used in 12 countries in Europe and the Middle East, and Allurion expects to have its 10,000th patient by the end of the year after two years on the market. The company is now enrolling 400 patients for a clinical study in the United States, with a plan to receive results next year and win U.S. Food & Drug Administration approval by 2020.
New non-surgical gastric balloon aids in weight loss
SPRINGWISE – A standard intragastric balloon procedure costs around 8000 USD, with about half of that from the cost of endoscopy. Without the need for the costly endoscopy, the Allurion procedure can save patients a considerable amount of money.
New devices to combat obesity, from three Boston-area firms
THE BOSTON GLOBE – Gastric balloons aren’t new, but traditionally they are inserted through the esophagus and into the stomach in an endoscopic procedure after the patient receives anesthesia. Allurion says the Elipse is the first “procedureless” balloon that can be swallowed when the patient is fully awake in a doctor’s office. “A patient can do it on his lunch break”.